Management of prosthetic joint infection

Reviews and Research in Medical Microbiology

Volumn 17, Issue 2, 2006, Pages 55-63

  Soriano, Alex ^a   García Ramiro, Sebastián ^a   Mensa, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antibiotics; Arthroplasty; Aseptic loosened; Debridement; Prosthesis related infection; Replacement

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; COTRIMOXAZOLE; FUSIDIC ACID; GLYCOPEPTIDE; LEVOFLOXACIN; LINEZOLID; OFLOXACIN; RIFAMPICIN;

ARTHROPLASTY; BACTERIAL GROWTH; BACTERIUM CULTURE; BIOFILM; BLOOD TOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; DEBRIDEMENT; DEVICE REMOVAL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG MECHANISM; HISTOLOGY; HUMAN; JOINT PROSTHESIS; LABORATORY TEST; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; NEUROTOXICITY; PATHOGENESIS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTHESIS INFECTION; RADIODIAGNOSIS; REVIEW;

EID: 33748341474     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.revmedmi.0000244135.50793.0a     Document Type: Review

References (54)

1. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003; 74:644-651.
2. Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, et al. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999; 37:3281-3290.
3. Schutzer SF, Harris WH. Deep-wound infection after total hip replacement under contemporary aseptic conditions. J Bone Joint Surg Am 1988; 70:724-727.
4. Carlsson AK, Lidgren L, Lindberg L. Prophylactic antibiotics against early and late deep infections after total hip replacements. Acta Orthop Scand 1977; 48:405-410.
5. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78:512-523.
6. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 1998; 27:1247-1254.
7. Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 2001; 392:15-23.
8. Murdoch DR, Roberts SA, Fowler JV Jr, Shah MA, Taylor SL, Morris AJ, et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001; 32:647-649.
9. Waldman BJ, Mont MA, Hungerford DS. Total knee arthroplasty infections associated with dental procedures. Clin Orthop Relat Res 1997; 343:164-172.
10. Ainscow DA, Denham RA. The risk of haematogenous infection in total joint replacements. J Bone Joint Surg Br 1984; 66:580-582.
11. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol 2001; 55:165-199.
12. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37:1771-1776.
13. Huang CT, Yu FP, McFeters GA, Stewart PS. Nonuniform spatial patterns of respiratory activity within biofilms during disinfection. Appl Environ Microbiol 1995; 61:2252-2256.
14. Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2003; 47:1251-1256.
15. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33:959-967.
16. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005; 70:267-274.
17. Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg Am 1999; 81:672-683.
18. Sastre S, Soriano A, Garcia S, Martínez JA, Suso S, Mensa J. Serum C-reactive protein as a predictor of infected arthroplasty. Eur J Orthop Surg Traumatol 2006; 16:17-19.
19. Moragas M, Lomena F, Herranz R, Garcia A, Piera C, Muxi A, et al. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection. Nucl Med Commun 1991; 12:417-427.
20. Glithero PR, Grigoris P, Harding LK, Hesslewood SR, McMinn DJ. White cell scans and infected joint replacements. Failure to detect chronic infection. J Bone Joint Surg Br 1993; 75:371-374.
21. Trampuz A, Hanssen AD, Osmon DR, Mandrekar J, Steckelberg JM, Patel R. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004; 117:556-562.
22. Rafiq M, Worthington T, Tebbs SE, Treacy RB, Dias R, Lambert PA, et al. Serological detection of Gram-positive bacterial infection around prostheses. J Bone Joint Surg Br 2000; 82:1156-1161.
23. Selan L, Passariello C, Rizzo L, Varesi P, Speziale F, Renzini G, et al. Diagnosis of vascular graft infections with antibodies against staphylococcal slime antigens. Lancet 2002; 359:2166-2168.
24. Bori G, Soriano A, Garcia S, Gallart X, Casanova L, Mallofre C, et al. Low sensitivity of histology to predict the presence of microorganisms in suspected aseptic loosening of a joint prosthesis. Mod Pathol 2006; 19:874-877.
25. Mirra JM, Amstutz HC, Matos M, Gold R. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop Relat Res 1976; 117:221-240.
26. Tunney MM, Patrick S, Gorman SP, Nixon JR, Anderson N, Davis RI, et al. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br 1998; 80:568-572.
27. Trampuz A, Piper KE, Hanssen AD, Osmon DR, Cockerill FR, Steckelberg JM, et al. Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol 2006; 44:628-631.
28. Nguyen LL, Nelson CL, Saccente M, Smeltzer MS, Wassell DL, McLaren SG. Detecting bacterial colonization of implanted orthopaedic devices by ultrasonication. Clin Orthop Relat Res 2002; 403:29-37.
29. Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 1990; 72:1383-1390.
30. Brandt CM, Sistrunk WW, Duffy MC, Hanssen AD, Steckelberg JM, Ilstrup DM, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24:914-919.
31. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42:471-478.
32. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998; 80:1306-1313.
33. Tattevin P, Cremieux AC, Pottier P, Huten D, Carbon C. Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 1999; 29:292-295.
34. Burger RR, Basch T, Hopson CN. Implant salvage in infected total knee arthroplasty. Clin Orthop 1991; 273:105-112.
35. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279:1537-1541.
36. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162:96-102.
37. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 2003; 51:1261-1268.
38. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37:1214-1218.
39. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14:1251-1253.
40. Soriano A, Garcia S, Bori G, Almela M, Gallart X, Macule F, et al. Treatment of acute postsurgical infection of joint arthroplasty. Clin Microbiol Infect 2006. in press.
41. Stein A, Bataille JF, Drancourt M, Curvale G, Argenson JN, Groulier P, et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim- sulfamethoxazole). Antimicrob Agents Chemother 1998; 42:3086-3091.
42. Bassetti M, Vitale F, Melica G, Righi E, Di Biagio A, Molfetta L, et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Chemother 2005; 55:387-390.
43. Bressler AM, Zimmer SM, Gilmore JL, Somani J. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004; 4:528-531.
44. Soriano A, Miro O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med 2005; 353:2305-2306.
45. Nijhof MW, Fleer A, Hardus K, Vogely HC, Schouls LM, Verbout AJ, et al. Tobramycin-containing bone cement and systemic cefazolin in a one-stage revision. Treatment of infection in a rabbit model. J Biomed Mater Res 2001; 58:747-753.
46. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br 2003; 85:637-640.
47. Hunter GA. The results of reinsertion of a total hip prosthesis after sepsis. J Bone Joint Surg Br 1979; 61-B:422-423.
48. Jupiter JB, Karchmer AW, Lowell JD, Harris WH. Total hip arthroplasty in the treatment of adult hips with current or quiescent sepsis. J Bone Joint Surg Am 1981; 63:194-200.
49. Salvati EA, Chekofsky KM, Brause BD, Wilson PD Jr. Reimplantation in infection: a 12-year experience. Clin Orthop 1982; 170:62-75.
50. Cherney DL, Amstutz HC. Total hip replacement in the previously septic hip. J Bone Joint Surg Am 1983; 65:1256-1265.
51. Garcia S, Soriano A, Esteban P, Almela M, Gallart X, Mensa J. Usefulness of adding antibiotic to cement in one stage exchange of chronic infection in total hip arthroplasty. Med Clin (Barc) 2005; 125:138-139.
52. Rao N, Crossett LS, Sinha RK, Le Frock JL. Long-term suppression of infection in total joint arthroplasty. Clin Orthop 2003; 414:55-60.
53. Pavoni GL, Giannella M, Falcone M, Scorzolini L, Liberatore M, Carlesimo B, et al. Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. Clin Microbiol Infect 2004; 10:831-837.
54. Trebse R, Pisot V, Trampuz A. Treatment of infected retained implants. J Bone Joint Surg Br 2005; 87:249-256.